Company profile
ATsens Co.,Ltd.
ATsens Co.,Ltd. has 1 AI-enabled medical device on the FDA list. The first decision was on May 2, 2025 and the most recent on May 2, 2025 (AT-Patch (ATP-C130/ATP-C70)). Its most common review panel is Cardiovascular (1 device).
1AI devices
2025First decision
2025Latest decision
1Specialties
Timeline
- AT-Patch (ATP-C130/ATP-C70) · Cardiovascular · DSH